Review: could Oxybutynin Chloride cause Macular Degeneration?


Summary

Macular degeneration is reported only by a few people who take Oxybutynin Chloride. We study 2,868 people who have side effects while taking Oxybutynin chloride from FDA and social media. Among them, 3 have Macular degeneration. Find out below who they are, when they have Macular degeneration and more.

You are not alone

Join a support group for people who take Oxybutynin chloride and have Macular degeneration >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Oxybutynin Chloride

Oxybutynin chloride has active ingredients of oxybutynin chloride. It is often used in urinary incontinence. (latest outcomes from Oxybutynin chloride 3,126 users)

Macular Degeneration

Macular degeneration (painless eye condition that leads to the gradual loss of central vision) has been reported by people with death, endophthalmitis, visual acuity reduced, stroke, eye haemorrhage (latest reports from 11,887 Macular degeneration patients).

On Aug, 28, 2016

2,868 people reported to have side effects when taking Oxybutynin Chloride.
Among them, 3 people (0.1%) have Macular Degeneration


Number of reports submitted per year:

Could Oxybutynin chloride cause Macular degeneration?

Gender of people who have Macular Degeneration when taking Oxybutynin Chloride *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Macular Degeneration when taking Oxybutynin Chloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Urinary Incontinence (3 people)
  • Macular Degeneration (3 people)
  • Hip Fracture (3 people)
  • Depression (3 people)
  • Chronic Obstructive Pulmonary Disease (3 people)

Top co-used drugs for these people *:

  • Theophylline (3 people)
  • Spiriva (3 people)
  • Ocuvite Lutein (3 people)
  • Lorazepam (3 people)
  • Calcium Chews (3 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Macular degeneration when taking Oxybutynin chloride?

Browse all side effects of Oxybutynin chloride

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Macular degeneration

Macular degeneration

Could your condition cause Macular degeneration

Macular degeneration

Can you answer these questions?

More questions for: Oxybutynin chloride, Macular degeneration

You may be interested in these reviews

More reviews for: Oxybutynin chloride, Macular degeneration


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.